top of page
external-file_edited.png

Webinar: What is imetelstat?

On October 23rd at 15:00 CET, the Global MPN Scientific Foundation will host an open-access webinar titled “What is imetelstat?” an investigational drug for Myelofibrosis, featuring Dr. Faye Feller, MD, Executive Vice President and Chief Medical Officer at Geron.


On October 23rd at 15:00 CET, the Global MPN Scientific Foundation will host an open-access webinar titled “What is imetelstat?” an investigational drug for Myelofibrosis, featuring Dr. Faye Feller, MD, Executive Vice President and Chief Medical Officer at Geron.

This session is designed to provide information about imetelstat, an investigational treatment currently in development for Myelofibrosis (MF), a type of myeloproliferative neoplasm (MPN). The presentation will focus on the drug’s proposed mechanism of action, the clinical development process, and current data available from trials.


🗓 Date: October 23rd, 2025

🕒 Time: 15:00 CET

💻 Format: Online webinar with simultaneous interpretation into Spanish

🎙 Speaker: Dr. Faye Feller, MD, Executive Vice President and Chief Medical Officer


The session is open to patients, caregivers, advocates, and healthcare professionals interested in learning more about new developments in MPN research.


Comments

bottom of page